These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38818946)

  • 41. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N; Wang K; Schlindwein W; Davies A; Li M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanistic insights into the crystallization of coamorphous drug systems.
    Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
    J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanistic Basis of Cocrystal Dissolution Advantage.
    Cao F; Amidon GL; Rodríguez-Hornedo N; Amidon GE
    J Pharm Sci; 2018 Jan; 107(1):380-389. PubMed ID: 28989017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating Cocrystallization of Carbamazepine with Structurally Compatible Coformers: New Cocrystal and Eutectic Phases with Enhanced Dissolution.
    Sathisaran I; Dalvi SV
    AAPS PharmSciTech; 2021 Jan; 22(1):29. PubMed ID: 33404968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sacubitril-valsartan cocrystal revisited: role of polymer excipients in the formulation.
    Zhang Y; Du X; Wang H; He Z; Liu H
    Expert Opin Drug Deliv; 2021 Apr; 18(4):515-526. PubMed ID: 33280447
    [No Abstract]   [Full Text] [Related]  

  • 46. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
    Newman A; Zografi G
    J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
    Sathisaran I; Dalvi SV
    Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of PVP/VA copolymer composition on drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S; Rudraraju VS
    AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
    Newman A; Zografi G
    Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
    Hurley D; Potter CB; Walker GM; Higginbotham CL
    J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissolution Profiles of Carbamazepine Cocrystals with Cis-Trans Isomeric Coformers.
    Omori M; Yamamoto H; Matsui F; Sugano K
    Pharm Res; 2023 Feb; 40(2):579-591. PubMed ID: 35194718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation.
    Ullah M; Shah MR; Bin Asad MHH; Hasan SMF; Hussain I
    Pak J Pharm Sci; 2017 Nov; 30(6):2139-2145. PubMed ID: 29175782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artemisinin Cocrystals for Bioavailability Enhancement. Part 1: Formulation Design and Role of the Polymeric Excipient.
    Kaur M; Yardley V; Wang K; Masania J; Botana A; Arroo RRJ; Li M
    Mol Pharm; 2021 Dec; 18(12):4256-4271. PubMed ID: 34723557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New cocrystals of heterocyclic drugs: structural, antileishmanial, larvicidal and urease inhibition studies.
    Murtaza G; Khan M; Farooq S; Choudhary MI; Yousuf S
    Acta Crystallogr C Struct Chem; 2023 Jun; 79(Pt 6):237-248. PubMed ID: 37140892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystallization of poly(ethylene oxide) with acetaminophen--a study on solubility, spherulitic growth, and morphology.
    Yang M; Gogos C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):889-97. PubMed ID: 23562611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of two DSC-based methods to predict drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Int J Pharm; 2018 Apr; 540(1-2):98-105. PubMed ID: 29425764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigating Permeation Behavior of Flufenamic Acid Cocrystals Using a Dissolution and Permeation System.
    Guo M; Wang K; Qiao N; Yardley V; Li M
    Mol Pharm; 2018 Sep; 15(9):4257-4272. PubMed ID: 30080976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.